Table 2. . TaqIB polymorphism: genotype and allele frequencies in the study population .
Controls | AF patients | p value | |||
---|---|---|---|---|---|
Total | n=109 | n=109 | |||
B2B2 | 14 (12.8%) | 25 (23.0%) | 0.0342 | ||
B1B2 | 62 (56.9%) | 44 (40.4%) | |||
B1B1 | 33 (30.3%) | 40 (36.6%) | |||
B2 allele | 90 (41.3%) | 94 (43.1%) | 0.4634 | ||
Male | n=53 | n=47 | |||
B2B2 | 9 (17.0%) | 7 (14.9%) | 0.7120 | ||
B1B2 | 29 (54.7%) | 23 (48.9%) | |||
B1B1 | 15 (28.3%) | 17 (36.2%) | |||
B2 allele | 47 (44.3%) | 37 (39.4%) | 0.1256 | ||
Female | n=56 | n=62 | |||
B2B2 | 5 (9.0%) | 18 (29.0%) | 0.0059 | ||
B1B2 | 33 (59.0%) | 21 (33.9%) | |||
B1B1 | 18 (32.0%) | 23 (37.1%) | |||
B2 allele | 43 (38.4%) | 57 (46.0%) | 0.0591 |